Litcius/Paper detail

Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials

Sonia L. Villegas, Valentina Nekljudova, Nicole Pfarr, Jutta Engel, Michael Untch, Simone Schrodi, Frank Holms, Hans Ulrich Ulmer, Peter A. Fasching, Karsten E. Weber, Christian Albig, C Heinrichs, Frederik Marmé, Arndt Hartmann, Claus Hanusch, Wolfgang Schmitt, Jens Huober, Bianca Lederer, Marion van Mackelenbergh, Hans Tesch, Christian Jackisch, Mahdi Rezai, Hans‐Peter Sinn, Bruno V. Sinn, John Hackmann, Marion Kiechle, Andreas Schneeweiß, Wilko Weichert, Carsten Denkert, Sibylle Loibl

2021European Journal of Cancer89 citationsDOI

Topics & Concepts

Breast cancerOncologyMedicineHormone receptorInternal medicineHormone therapyHormoneClinical trialNeoadjuvant therapyCancerGynecologyBreast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer Research
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials | Litcius